We are live on ! Find out more
CRVO icon

CervoMed

38 hedge funds and large institutions have $59M invested in CervoMed in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 2

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

90% more funds holding

Funds holding: 2038 (+18)

1.03% more ownership

Funds ownership: 40.75%41.78% (+1%)

1% more capital invested

Capital invested by funds: $58.6M → $59M (+$427K)

Holders
38
Holders Change
+18
Holders Change %
+90%
% of All Funds
0.55%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
20
Increased
7
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change

CRVO Hedge Fund Activity: Q2 2024 in Review

38 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q2 2024, worth a combined $59M — up 0.73% from $58.6M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new CRVO positions and 2 closed out — a net gain of 18 holders — while 7 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $8.34M. The largest seller was Adage Capital Partners, cutting an estimated $3.48M.

  • 38 institutional investors held CervoMed (CRVO) as of Q2 2024, up from 20 in Q1 2024.
  • Funds reported $59M of CervoMed stock for Q2 2024, up 0.73% quarter-over-quarter.
  • 20 funds opened new CervoMed positions in Q2 2024 and 2 closed out, a net change of +18 holders.
  • The largest CervoMed buyer in Q2 2024 was Vanguard Group, an estimated $8.34M added.
  • The largest CervoMed seller in Q2 2024 was Adage Capital Partners, an estimated $3.48M sold.

Based on aggregated 13F filings for Q2 2024.